Browsing Tag
China
667 posts
Lilly, Innovent Biologics expand licensing deal for blood cancer drug Tyvyt
Eli Lilly and Company has signed an expanded licensing deal worth up to $1 billion with Chinese biotech…
G42 Healthcare begins late-stage trial for Sinopharm COVID-19 vaccine
Find out how Sinopharm and G42 Healthcare are advancing the world’s first phase 3 COVID-19 vaccine trial in the UAE.
Chinese regulator accepts NDA of BeiGene’s pamiparib in ovarian cancer
BeiGene said that the Center for Drug Evaluation (CDE) of the China National Medical Products Administration (NMPA) has…
Danone injects €100m to bolster specialized nutrition business in China
Danone said that it is investing €100 million in China for bolstering its specialized nutrition business in China…
Sinovac Biotech gets approval for CoronaVac phase 3 trial in Brazil
CoronaVac phase 3 trial : Sinovac Biotech, a Chinese biopharma company has secured approval in Brazil to begin…
China’s CF PharmTech raises $50m in Series F round for inhalation products
CF PharmTech, a Chinese pharma company, has raised $50 million in a Series F financing round to accelerate…
SmartSens acquires CMOS image sensors firm Allchip Microelectronics
SmartSens Technology has wrapped up its acquisition and merger with Shenzhen-based Allchip Microelectronics, a provider of CMOS image…
Shandong Gold Mining offers to acquire Cardinal Resources for $221m
Shandong Gold Mining, a Chinese state-owned gold mining company, has offered to acquire Cardinal Resources, a West African…
Sinovac Biotech CoronaVac COVID-19 vaccine candidate succeeds in phase 1/2 trial
Sinovac Biotech said that the phase 1/2 clinical trial for its coronavirus vaccine candidate CoronaVac has delivered positive…
Munich Re’s ERGO to buy 25% stake in China-based Taishan Insurance
Germany-based ERGO Group, a subsidiary of Munich Re, has agreed to acquire a 24.9% stake in Taishan Property…